35 Proteomics, Genomics & Microarrays The Ultimate Customisable Biomolecular Imager
Azure Biosystems announces the release of the Sapphire FL Biomolecular Imager, a ground-breaking new imaging system which introduces a patent- pending, fully customisable, user-interchangeable laser-filter module mechanism that allows you to either choose the laser-filter pairs best suited for your research, or create your own laser-filter pairs.
The new Sapphire FL supports multicolour visible, chemiluminesent, phosphor imaging, and NIR fluorescence with excitation wavelengths between 365 nm and 850 nm and emission wavelengths between 380 nm and 900 nm.
It has a large 25 cm x 25 cm imaging area with a 4-cm clearance and upgraded high-resolution abilities that now allow you to image down to 5 microns. In addition to imaging flat samples such as gels, membranes, and slides, the Sapphire FL can image 3D samples, like petri dishes, multi-well plates, plants, tissues, and small, live experimental animals, thanks to five built-in anaesthesia ports. The application list is almost limitless. Request a demo by contacting Azure Biosystems.
More information online:
ilmt.co/PL/mVYj and
ilmt.co/PL/KeXe 60527pr@reply-direct.com
New Electroporation System Enhances Cell Transfection
Thermo Fisher Scientific has released the Invitrogen Neon NxT Electroporation System, a state-of-the-art device that maximises the transfection efficiency, cell recovery, and reproducibility of challenging cell types.
Thanks to the optimally spaced Neon NxT electrodes, which create a uniform electric field, scientists can achieve desired cell modifications in a greater number of cells while losing fewer during the transfection process. The device also includes ergonomic enhancements and an improved feedback loop.
The Neon NxT system is built on the core technology of the Neon Transfection System and simplifies electroporation while reducing cell mortality and contamination risk. The new system’s scalability enables researchers to move from initial research to clinical cell therapy development and GMP-compliant cell therapy manufacturing without re-optimising electroporation parameters. The device is suitable for gene and protein expression research, cell line development, gene silencing, and genome editing.
More information online:
ilmt.co/PL/z18Q 60301pr@reply-direct.com ADVERTORIAL INTEGRA Biosciences Expands Genomics Capabilities with Acquisition of Miroculus
INTEGRA Biosciences has recently acquired Miroculus, a leading biotechnology specialist that is dedicated to developing automation solutions for next-generation sequencing (NGS) protocols. With this acquisition, INTEGRA is set to broaden its range of products for library preparation, providing valuable time-saving benefi ts to academic, research, and diagnostics laboratories that utilize NGS. The acquisition of Miroculus will ultimately help to accelerate the pace of discovery in this ever-evolving fi eld.
Miroculus is based in San Francisco, California, and was founded to develop innovative and intuitive tools that simplify complex genomics protocols, making them accessible to a wider range of scientists. Urs Hartmann, CEO of INTEGRA, said: “We have acquired this promising start-up because we recognize the huge potential of its revolutionary digital microfl uidics technology for automating and miniaturizing genomics protocols. Miroculus’ proprietary platform delivers assay fl exibility and automation capacity, which enables seamless workfl ow integration, streamlining the experimental process and empowering researchers to translate their discoveries into practical solutions that will improve people’s lives.”
INTEGRA acquired Miroculus in order to better serve the growing NGS market with novel and precise solutions for applications such as automating long-read sequencing and target enrichment protocols. The acquisition also ensures ongoing company growth and safeguards staff; high priorities for both companies. Urs continued: “Miroculus’ vision and product range complement our own innovative solutions for sample and library preparation, making it the perfect fi t for our company as we seek to establish a competitive edge in the genomics sector. We’re very much looking forward to welcoming the Miroculus team into the INTEGRA family, and we’ll no doubt benefi t from their expertise and wealth of knowledge surrounding NGS. We are confi dent that our combined talents will allow us to accelerate and simplify science together, and we anticipate the launch of many exciting projects in the near future, with the aim of advancing discoveries in the crucial area of genomics.”
AFFORDABLE MICROPLATE DISPENSING IN A SNAP
Alejandro Tocigl, Co-Founder and CEO of Miroculus, added: “We began Miroculus with the mission to advance science and improve lives faster, and the last year has been signifi cant for us as we’ve worked toward this goal. Most notably, we launched the Miro Canvas™ system, which is a compact and easy-to-use digital microfl uidics platform that fully automates NGS sample preparation protocols and makes them accessible to scientists everywhere. We are extremely excited to now be a part of INTEGRA and to continue our shared culture of innovation for the scientifi c community.”
More information online:
ilmt.co/PL/jXWJ 60263pr@reply-direct.com
Miroculus team members welcome Integra visitors to their offi ce in San Francisco.
WELLJET Reagent Dispenser
The WELLJET dispenser and dispenser stacker together with the EasySnap™ dispensing cassette offer superior user experience and flexibility for applications requiring low cost and precise reagent dispensing at minimal benchspace.
Your choice to save money, space and time!
integra-biosciences.com
Revolutionary cassette technology for lower running costs!
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56
